...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Anti-AIDS agents 86. Synthesis and anti-HIV evaluation of 2',3'-seco-3'-nor DCP and DCK analogues.
【24h】

Anti-AIDS agents 86. Synthesis and anti-HIV evaluation of 2',3'-seco-3'-nor DCP and DCK analogues.

机译:抗艾滋病剂86. 2',3'-seco-3'-nor DCP和DCK类似物的合成和抗HIV评估。

获取原文
获取原文并翻译 | 示例
           

摘要

In a continuing study of novel anti-HIV agents with drug-like structures and properties, 30 1'-O-, 1'-S-, 4'-O- and 4'-substituted-2',3'-seco-3'-nor DCP and DCK analogues (8-37) were designed and synthesized. All newly synthesized seco-compounds were screened against HIV-1(NL4-3) and a multiple reverse transcriptase (RT) inhibitor-resistant (RTMDR) strain in the TZM-bl cell line, using seco-DCK (7) and 2-ethyl-DCP (4) as controls. Several compounds (14, 18, 19, 22-24, and 32) exhibited potent anti-HIV activity with EC(50) values ranging from 0.93 to 1.93 muM and therapeutic index (TI) values ranging from 20 to 39. 1'-O-Isopropoxy-2',3'-seco-3'-nor-DCP (12) showed the greatest potency among the newly synthesized compounds with EC(50) values of 0.47 and 0.88 muM, and TI of 96 and 51, respectively, against HIV-1(NL4-3) and RTMDR strains. The seco-compounds exhibited better chemical stability in acidic conditions compared with DCP and DCK compounds. Overall, the results suggested that seco-DCP analogues with simplified structures may be more favorable for development as novel anti-HIV candidates.
机译:在对具有药物样结构和性质的新型抗HIV药物的持续研究中,有30种1'-O-,1'-S-,4'-O-和4'-取代的2',3'-seco-设计并合成了3'-nor DCP和DCK类似物(8-37)。使用seco-DCK(7)和2-筛选了所有新合成的山高化合物针对TZM-b1细胞系中的HIV-1(NL4-3)和多重逆转录酶(RT)抑制剂耐药(RTMDR)菌株。乙基-DCP(4)作为对照。几种化合物(14、18、19、22-24和32)表现出有效的抗HIV活性,其EC(50)值为0.93至1.93μM,治疗指数(TI)值为20至39。1'- O-异丙氧基-2',3'-seco-3'-nor-DCP(12)在新合成的化合物中具有最大的效价,EC(50)值为0.47和0.88μM,TI分别为96和51 ,针对HIV-1(NL4-3)和RTMDR毒株。与DCP和DCK化合物相比,山高的化合物在酸性条件下表现出更好的化学稳定性。总体而言,结果表明,结构简化的山高DCP类似物可能更适合作为新型抗HIV候选药物开发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号